Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending October 6, 2019 Ovarian Function Suppression Gains Support for Premenopausal Breast Cancer, Supine sleep in late pregnancy may promote low birth weight, High maternal lead levels linked to children’s obesity, Systematic Review Indicates Cutaneous Laser Therapy May Be Safe During Pregnancy, More must reads Must reads for theWeek ending September 29, 2019 PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer, Early maternal anxiety tied to adolescent hyperactivity, High-Dose Vitamin D for Bone Health May Do More Harm Than Good, High-Dose Teriparatide Tops Standard Dose in Boosting BMD in Postmenopausal Women With Osteoporosis, Zoledronate Maintains Bone Loss After Denosumab Discontinuation, More must readsMust reads for theWeek ending September 22, 2019 Closure of women’s health clinics may negatively impact cervical cancer outcomes, No link found between sleep position, pregnancy outcomes, USPSTF: Preventive Breast Cancer Medications Only for Women at Risk, Most practices not screening for five social needs, Trial of mesh vs. hysterectomy for prolapse yields inconclusive results, More must readsMust reads for theWeek ending September 15, 2019 Survival at ‘overweight’ BMI surpasses ‘normal’, FRAX With BMD May Not be Accurate for Women With Diabetes, No Mortality Reductions Found With Osteoporosis Drugs, Zoledronic Acid Reduces Symptomatic Periodontal Disease in Patients With Osteoporosis, Oral drug for postpartum depression aces phase 3 trial, More must readsMust reads for theWeek ending September 8, 2019 Chlamydia trachomatis is associated with adverse reproductive health outcomes, Diet, Exercise Don’t Improve Breast Cancer-related Lymphedema, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 last »
